| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500268 | Farmacia Hospitalaria | 2010 | 8 Pages |
Abstract
The results of the combined effectiveness analysis in the meta-analysis found no significant differences between the conventional strategy and monotherapy. This strategy is considered recommended (level A evidence) in patients with no history of previous failure of protease inhibitor, with undetectable plasma viral load and signs or symptoms of nucleoside/nucleotide toxicity.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
J. Saez de la Fuente, A. Such DÃaz, C. Sánchez Gil, C. Esteban Alba, I. Escobar RodrÃguez,